Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications

被引:158
|
作者
Berger, C
deMuret, A
Garaud, P
Chapet, S
Bourlier, P
ReynaudBougnoux, A
Dorval, E
deCalan, L
Huten, N
leFloch, O
Calais, G
机构
[1] HOP BRETONNEAU, CLIN ONCOL & RADIOTHERAPIE, TOURS, FRANCE
[2] HOP TROUSSEAU, ANAT PATHOL LAB, TOURS, FRANCE
[3] CHRU BRETONNEAU, LAB PATHOL CELLULAIRE, TOURS, FRANCE
[4] HOP TROUSSEAU, MALADIES APPAREIL DIGESTIF & NUTR, TOURS, FRANCE
[5] HOP TROUSSEAU, SERV CHIRURG DIGEST, TOURS, FRANCE
关键词
rectal carcinoma; preoperative radiotherapy; tumor downstaging; tumor sterilization; prognostic factors;
D O I
10.1016/S0360-3016(96)00577-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine predictive factors and prognostic value of tumor downstaging and tumor sterilization after preoperative RT for rectal cancer. Methods and Materials: Between 1977 and 1994, 167 patients with a histologically proven adenocarcinoma (70 T2, 65 T3, 29 T4, and 3 local recurrences) underwent preoperative RT. Median dose was 44 Gy (5-73 Gy). Surgery was performed in a mean time of 5 weeks after RT. Pathologic specimens have been reviewed by the same pathologist in order to specify the modified Astler Coller classification (MAC), and to quantify the residual tumor cell density (RTCD). Results: According to the MAC, there was 9 stage 0 (5%), 10 stage A (6%), 103 stage B1-B3 (62%), and 45 stage C1-C3 (27%) tumors. Seventeen percent and 56% of the patients who received a dose greater than or equal to 44 Gy had respectively a 0-A and a B tumor, compared to 4 and 69% in those who received a dose <44 Gy (p = 0.04). Tumor differentiation and a longer interval before surgery were significantly associated with a more frequent downstaging, and preoperative staging correlated well to the postoperative pathological findings. According to the RTCD, 62 tumors (37%) showed no or only rare foci of residual tumor cells (Group 1); 62 (37%) showed an intermediate RTCD (Group 2); and 43 (26%) a high RTCD (Group 3). No predictive factor of RTCD was statistically significant. In univariate analysis, postoperative staging was a significant prognostic factor, with corresponding 5-year overall survival rates in 0-A, B, and C stages of 92, 67, and 26% (p < 0.01). RTCD was not a prognostic factor. However, overall and disease-free survival rates for patients with complete pathologic response of 83% at 2 and 5 years suggested a better outcome in this subgroup of patients. Conclusion: The favorable influence of higher doses of preoperative RT on pathologic stage has been observed. Tumor differentiation, preoperative classification and time before surgery were the other predictive factors of tumor downstaging. However, there was no predictive factor of complete pathologic response. Even after preoperative RT, postoperative staging remained a prognostic factor. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 50 条
  • [21] Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
    Rödel, C
    Martus, P
    Papadoupolos, T
    Füzesi, L
    Klimpfinger, M
    Fietkau, R
    Liersch, T
    Hohenberger, W
    Raab, R
    Sauer, R
    Wittekind, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8688 - 8696
  • [22] Prognostic value of preoperative metabolic tumor volume in patients with rectal cancer
    Hong, Chae Moon
    Ahn, Byeong-Cheol
    Kim, Do-Hoon
    Lee, Sang-Woo
    Lee, Jaetae
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
    Cai, Du
    Huang, Zeng-Hong
    Yu, Hui-Chuan
    Wang, Xiao-Lin
    Bai, Liang-Liang
    Tang, Guan-Nan
    Peng, Shao-Yong
    Li, Ying-Jie
    Huang, Mei-Jin
    Cao, Guang-Wen
    Wang, Jian-Ping
    Luo, Yan-Xin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (33) : 4945 - 4958
  • [24] Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
    Du Cai
    Zeng-Hong Huang
    Hui-Chuan Yu
    Xiao-Lin Wang
    Liang-Liang Bai
    Guan-Nan Tang
    Shao-Yong Peng
    Ying-Jie Li
    Mei-Jin Huang
    Guang-Wen Cao
    Jian-Ping Wang
    Yan-Xin Luo
    World Journal of Gastroenterology, 2019, (33) : 4945 - 4958
  • [25] Mandard tumor regression grade as a prognostic factor following preoperative chemotherapy/radiotherapy for locally advanced rectal cancer
    Dhadda, A. S.
    Dickinson, P. D.
    Zaitoun, A. M.
    Besse, E. M., II
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome
    Prausova, J.
    Lohynska, R.
    Kubackova, K.
    Linke, Z.
    Malinova, B.
    Kubala, E.
    Novotny, J., Jr.
    NEOPLASMA, 2006, 53 (03) : 263 - 268
  • [27] Gastric cancer: Tumor markers as predictive factors for preoperative staging
    Cidón E.U.
    Bustamante R.
    Journal of Gastrointestinal Cancer, 2011, 42 (3) : 127 - 130
  • [28] Preoperative radiotherapy of the rectal cancer, local tumor control according to the grade of malignancy
    Mihaylov, IS
    Parvanova, VM
    Deliisky, TS
    Timcheva, KV
    ANNALS OF ONCOLOGY, 2005, 16 : 288 - 288
  • [29] Pathological prognostic factors for locally advanced rectal cancer (LARC) treated with preoperative radiotherapy (P-RT) and capecitabine (C)
    Asin, G.
    Arias, F.
    Balen, E.
    Arrazubi, V.
    Gomez-Dorronsoro, M. L.
    Ortiz, H.
    Montes, M.
    Vera, R.
    Rico, M.
    Dominguez, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S273 - S273
  • [30] INTRAOPERATIVE AND EXTERNAL PREOPERATIVE RADIOTHERAPY IN INVASIVE BLADDER-CANCER - EFFECT OF NEOADJUVANT CHEMOTHERAPY IN TUMOR DOWNSTAGING
    CALVO, FA
    ARISTU, JJ
    ABUCHAIBE, O
    REBOLLO, J
    HIDALGO, OF
    ZUDAIRE, J
    BERIAN, JM
    AZINOVIC, I
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 61 - 66